$3.25 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 32.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $619,916,000 | -16.4% | 4,629,700 | +5.2% | 19.07% | -4.4% |
| IYR | ISHARES TRput | $224,820,000 | -6.3% | 3,000,000 | 0.0% | 6.92% | +7.1% | |
| IWM | New | ISHARES TRcall | $207,893,000 | – | 1,552,600 | +100.0% | 6.40% | – |
| FCAU | Buy | FIAT CHRYSLER AUTOMOBILES Ncall | $129,706,000 | -7.1% | 8,970,000 | +12.5% | 3.99% | +6.3% |
| SGMS | Buy | SCIENTIFIC GAMES CORPcall | $124,593,000 | -24.3% | 6,968,300 | +7.6% | 3.83% | -13.4% |
| CDXS | Sell | CODEXIS INC | $109,382,000 | -4.5% | 6,549,800 | -1.9% | 3.36% | +9.1% |
| HCA | HCA HEALTHCARE INCput | $87,115,000 | -10.5% | 700,000 | 0.0% | 2.68% | +2.3% | |
| RH | Buy | RHcall | $81,250,000 | +4.0% | 678,100 | +13.8% | 2.50% | +19.0% |
| WRLD | Buy | WORLD ACCEP CORP DEL | $75,871,000 | -8.8% | 741,945 | +2.0% | 2.33% | +4.3% |
| XBI | SPDR SERIES TRUSTput | $71,750,000 | -25.2% | 1,000,000 | 0.0% | 2.21% | -14.4% | |
| QURE | Buy | UNIQURE NV | $71,435,000 | +4.3% | 2,478,667 | +31.7% | 2.20% | +19.3% |
| EXAS | Sell | EXACT SCIENCES CORPput | $70,041,000 | -70.2% | 1,110,000 | -62.7% | 2.16% | -65.9% |
| SPY | New | SPDR S&P 500 ETF TRput | $62,480,000 | – | 250,000 | +100.0% | 1.92% | – |
| VAC | New | MARRIOTT VACATIONS WRLDWDE C | $55,992,000 | – | 794,096 | +100.0% | 1.72% | – |
| THC | Buy | TENET HEALTHCARE CORPcall | $50,992,000 | +40.5% | 2,975,000 | +133.3% | 1.57% | +60.8% |
| AABA | Sell | ALTABA INC | $49,993,000 | -37.4% | 862,841 | -26.4% | 1.54% | -28.4% |
| CVNA | New | CARVANA COcall | $47,430,000 | – | 1,450,000 | +100.0% | 1.46% | – |
| LXFR | Sell | LUXFER HOLDINGS PLC | $46,468,000 | -24.5% | 2,635,749 | -0.4% | 1.43% | -13.6% |
| PRTY | Buy | PARTY CITY HOLDCO INC | $43,710,000 | +36.2% | 4,379,789 | +84.9% | 1.34% | +55.7% |
| THC | Buy | TENET HEALTHCARE CORP | $42,389,000 | -29.4% | 2,473,112 | +17.3% | 1.30% | -19.3% |
| GDEN | Buy | GOLDEN ENTMT INC | $40,494,000 | -29.9% | 2,527,713 | +5.0% | 1.25% | -19.9% |
| QADA | Buy | QAD INCcl a | $39,672,000 | -15.9% | 1,008,709 | +21.1% | 1.22% | -3.9% |
| CASH | Buy | META FINL GROUP INC | $34,596,000 | -22.4% | 1,784,227 | +230.7% | 1.06% | -11.3% |
| ARQL | ARQULE INC | $33,522,000 | -51.1% | 12,101,879 | 0.0% | 1.03% | -44.1% | |
| XELA | Buy | EXELA TECHNOLOGIES INC | $32,683,000 | -31.2% | 8,401,832 | +26.1% | 1.01% | -21.3% |
| DXPE | Buy | DXP ENTERPRISES INC NEW | $31,959,000 | -17.5% | 1,147,964 | +18.7% | 0.98% | -5.8% |
| QURE | Sell | UNIQURE NVcall | $31,702,000 | -51.6% | 1,100,000 | -38.9% | 0.98% | -44.7% |
| CVNA | Buy | CARVANA COcl a | $28,775,000 | -33.8% | 879,714 | +19.6% | 0.88% | -24.4% |
| CURO | Buy | CURO GROUP HLDGS CORP | $28,116,000 | -37.0% | 2,962,738 | +100.6% | 0.86% | -28.0% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $28,004,000 | -32.9% | 5,064,089 | +7.2% | 0.86% | -23.2% |
| DLB | Sell | DOLBY LABORATORIES INC | $26,356,000 | -14.8% | 426,193 | -3.6% | 0.81% | -2.5% |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $25,996,000 | +21.5% | 2,173,556 | +22.1% | 0.80% | +38.9% |
| AFI | Buy | ARMSTRONG FLOORING INC | $24,270,000 | -24.5% | 2,049,813 | +15.4% | 0.75% | -13.6% |
| ONDK | Buy | ON DECK CAP INC | $24,048,000 | -16.4% | 4,075,942 | +7.3% | 0.74% | -4.4% |
| HTZGQ | Sell | HERTZ GLOBAL HLDGS INCcall | $24,012,000 | -18.3% | 1,759,100 | -2.3% | 0.74% | -6.6% |
| GTTN | Buy | GTT COMMUNICATIONS INC | $20,977,000 | +128.4% | 886,581 | +318.9% | 0.64% | +161.1% |
| CZR | Buy | CAESARS ENTMT CORPcall | $20,370,000 | -20.5% | 3,000,000 | +20.0% | 0.63% | -9.0% |
| HRB | BLOCK H & R INCput | $20,296,000 | -1.5% | 800,000 | 0.0% | 0.62% | +12.6% | |
| SGMS | Buy | SCIENTIFIC GAMES CORP | $20,065,000 | +177.1% | 1,122,185 | +293.6% | 0.62% | +216.4% |
| CRHM | Buy | CRH MEDICAL CORP | $20,028,000 | -18.3% | 6,534,155 | +6.1% | 0.62% | -6.7% |
| ENT | Sell | GLOBAL EAGLE ENTMT INC | $19,749,000 | -22.2% | 8,855,876 | -1.6% | 0.61% | -11.0% |
| TBBK | Buy | BANCORP INC DEL | $19,644,000 | -15.7% | 2,467,817 | +1.6% | 0.60% | -3.7% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $18,929,000 | -21.7% | 2,527,260 | 0.0% | 0.58% | -10.6% | |
| ACER | Buy | ACER THERAPEUTICS INC | $18,178,000 | -14.7% | 903,455 | +30.7% | 0.56% | -2.6% |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $17,963,000 | +11.0% | 2,273,738 | -3.2% | 0.55% | +27.1% |
| BPI | Buy | BRIDGEPOINT ED INC | $16,466,000 | -16.1% | 2,348,865 | +21.6% | 0.51% | -4.0% |
| RH | Buy | RH | $14,758,000 | +45.7% | 123,169 | +59.3% | 0.45% | +66.3% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $13,599,000 | +182.1% | 495,958 | +148.0% | 0.42% | +221.5% |
| Sell | FALCON MINERALS CORP | $12,526,000 | -26.0% | 1,473,608 | -4.2% | 0.38% | -15.4% | |
| PAR | Buy | PAR TECHNOLOGY CORP | $12,110,000 | +393.3% | 556,799 | +403.9% | 0.37% | +465.2% |
| OZK | New | BANK OZK | $11,415,000 | – | 500,000 | +100.0% | 0.35% | – |
| ORM | Sell | OWENS RLTY MTG INC | $11,336,000 | +0.3% | 603,282 | -9.9% | 0.35% | +14.8% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $10,114,000 | +116.7% | 2,733,567 | +64.0% | 0.31% | +146.8% |
| GM | GENERAL MTRS COput | $10,035,000 | -0.7% | 300,000 | 0.0% | 0.31% | +13.6% | |
| JYNT | Buy | JOINT CORP | $9,391,000 | +7.2% | 1,128,693 | +10.1% | 0.29% | +22.5% |
| GME | New | GAMESTOP CORP NEWcl a | $9,232,000 | – | 731,500 | +100.0% | 0.28% | – |
| SCVL | New | SHOE CARNIVAL INCput | $9,044,000 | – | 269,900 | +100.0% | 0.28% | – |
| RMBL | Buy | RUMBLEON INCcl b | $8,793,000 | +222.3% | 1,634,350 | +527.8% | 0.27% | +271.2% |
| FTACU | New | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $8,427,000 | – | 842,730 | +100.0% | 0.26% | – |
| LINC | Buy | LINCOLN EDL SVCS CORP | $7,798,000 | +42.8% | 2,436,805 | +0.8% | 0.24% | +63.3% |
| TLYS | Buy | TILLYS INCcl a | $7,733,000 | -20.3% | 712,103 | +39.1% | 0.24% | -8.8% |
| NEOS | New | NEOS THERAPEUTICS INC | $7,400,000 | – | 4,485,000 | +100.0% | 0.23% | – |
| DHX | Buy | DHI GROUP INC | $7,310,000 | -24.1% | 4,809,253 | +4.8% | 0.22% | -13.1% |
| IGT | New | INTERNATIONAL GAME TECHNOLOGcall | $7,315,000 | – | 500,000 | +100.0% | 0.22% | – |
| SSKN | Buy | STRATA SKIN SCIENCES INC | $7,197,000 | -20.5% | 2,768,001 | +8.2% | 0.22% | -9.4% |
| ELVT | Buy | ELEVATE CREDIT INC | $7,089,000 | +98.3% | 1,582,364 | +256.8% | 0.22% | +127.1% |
| VIVE | Buy | VIVEVE MED INC | $6,911,000 | -34.7% | 6,581,465 | +66.7% | 0.21% | -25.3% |
| CCXI | Sell | CHEMOCENTRYX INC | $6,801,000 | -16.4% | 623,338 | -3.1% | 0.21% | -4.6% |
| CBIO | New | CATALYST BIOSCIENCES INC | $6,748,000 | – | 855,243 | +100.0% | 0.21% | – |
| FLWS | Sell | FLWS/1-800 FLOWERScl a | $6,228,000 | -9.3% | 509,217 | -12.5% | 0.19% | +3.8% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $6,074,000 | -28.9% | 1,760,562 | +47.7% | 0.19% | -18.7% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $5,699,000 | -50.0% | 834,401 | -0.5% | 0.18% | -42.8% |
| FTDCQ | FTD COS INC | $5,492,000 | -43.7% | 3,710,763 | 0.0% | 0.17% | -35.7% | |
| KIRK | Buy | KIRKLANDS INCput | $4,765,000 | +57.4% | 500,000 | +66.7% | 0.15% | +81.5% |
| NATR | Buy | NATURES SUNSHINE PRODUCTS IN | $4,756,000 | -5.8% | 583,510 | +1.2% | 0.15% | +7.4% |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $4,683,000 | – | 452,944 | +100.0% | 0.14% | – |
| CEMI | New | CHEMBIO DIAGNOSTICS INC | $4,641,000 | – | 820,000 | +100.0% | 0.14% | – |
| GAIA | Buy | GAIA INC NEWcl a | $4,597,000 | -28.6% | 443,698 | +6.1% | 0.14% | -18.5% |
| SHOS | Sell | SEARS HOMETOWN & OUTLET STOR | $4,550,000 | -28.5% | 2,136,251 | -1.8% | 0.14% | -18.1% |
| RFL | Buy | RAFAEL HLDGS INC | $4,500,000 | +21.5% | 567,511 | +28.7% | 0.14% | +38.0% |
| MFCB | Buy | MFC BANCORP LTD | $4,402,000 | -4.4% | 846,555 | +12.2% | 0.14% | +8.9% |
| CUE | Buy | CUE BIOPHARMA INC | $4,127,000 | -46.5% | 878,098 | +2.9% | 0.13% | -38.9% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $3,785,000 | -44.1% | 427,710 | -28.9% | 0.12% | -36.3% |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $3,613,000 | +1.5% | 1,358,100 | +113.6% | 0.11% | +15.6% |
| DDE | DOVER DOWNS GAMING & ENTMT I | $3,217,000 | -2.5% | 1,161,233 | 0.0% | 0.10% | +11.2% | |
| DVD | Sell | DOVER MOTORSPORTS INC | $3,226,000 | -13.0% | 1,715,899 | -0.6% | 0.10% | -1.0% |
| TA | TRAVELCENTERS AMER LLC | $2,855,000 | -34.0% | 759,401 | 0.0% | 0.09% | -24.1% | |
| DRIO | New | DARIOHEALTH CORP | $2,698,000 | – | 3,350,981 | +100.0% | 0.08% | – |
| EMMS | Sell | EMMIS COMMUNICATIONS CORP | $2,621,000 | -54.1% | 821,783 | -24.8% | 0.08% | -47.4% |
| AKBA | Sell | AKEBIA THERAPEUTICS INCcall | $2,289,000 | -69.5% | 414,000 | -51.4% | 0.07% | -65.3% |
| RLGT | RADIANT LOGISTICS INC | $2,233,000 | -28.1% | 525,300 | 0.0% | 0.07% | -17.9% | |
| MOTS | New | MOTUS GI HLDGS INC | $1,555,000 | – | 500,000 | +100.0% | 0.05% | – |
| STRM | STREAMLINE HEALTH SOLUTIONS | $1,426,000 | -32.8% | 1,760,297 | 0.0% | 0.04% | -22.8% | |
| CHACU | New | CHARDAN HEALTHCARE ACQUISITIunit 12/13/2023 | $1,007,000 | – | 100,000 | +100.0% | 0.03% | – |
| ASCMA | ASCENT CAP GROUP INC | $714,000 | -77.5% | 1,794,260 | 0.0% | 0.02% | -74.1% | |
| FALCON MINERALS CORP*w exp 07/21/202 | $527,000 | -64.7% | 878,022 | 0.0% | 0.02% | -60.0% | ||
| RRTS | Sell | ROADRUNNER TRNSN SVCS HLDG I | $476,000 | -80.7% | 948,178 | -67.8% | 0.02% | -77.3% |
| RBCAA | REPUBLIC BANCORP KYcl a | $285,000 | -16.2% | 7,371 | 0.0% | 0.01% | 0.0% | |
| IMXIW | Exit | INTERNATIONAL MNY EXPRESS IN*w exp 01/19/202 | $0 | – | -249,999 | -100.0% | -0.02% | – |
| PTIE | Exit | PAIN THERAPEUTICS INC | $0 | – | -647,053 | -100.0% | -0.02% | – |
| SHLDQ | Exit | SEARS HLDGS CORP | $0 | – | -789,201 | -100.0% | -0.02% | – |
| SHLDQ | Exit | SEARS HLDGS CORPcall | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
| SHLDQ | Exit | SEARS HLDGS CORPput | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
| RRR | Exit | RED ROCK RESORTS INCput | $0 | – | -200,000 | -100.0% | -0.14% | – |
| F | Exit | FORD MTR CO DELput | $0 | – | -700,000 | -100.0% | -0.17% | – |
| PCG | Exit | PG&E CORP | $0 | – | -205,000 | -100.0% | -0.25% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -8,263,335 | -100.0% | -0.38% | – |
| ADT | Exit | ADT INCcall | $0 | – | -2,000,000 | -100.0% | -0.50% | – |
| SODA | Exit | SODASTREAM INTERNATIONAL LTD | $0 | – | -204,865 | -100.0% | -0.79% | – |
| NTRI | Exit | NUTRI SYS INC NEWput | $0 | – | -1,000,000 | -100.0% | -1.00% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -150,000 | -100.0% | -1.17% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -400,000 | -100.0% | -1.31% | – |
| SODA | Exit | SODASTREAM INTERNATIONAL LTDcall | $0 | – | -440,600 | -100.0% | -1.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.